Profil bibliographique

Vasilios G. Athyros

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

553Publications signalées

17443Citations signalées

0Affiliations récentes

Domaines associés

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsLiver Disease Diagnosis and TreatmentCancer, Lipids, and MetabolismBlood Pressure and Hypertension Studies

Publications récentes

Accès ouvert 2025 articleOpenAlex

Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES

Philippe Gabríel Steg, Michael Szarek, J. Wouter Jukema, Deepak L. Bhatt et autres

25 citationsCirculation

Accès ouvert 2024 articleOpenAlex

Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation

Shaun G. Goodman, Philippe Gabríel Steg, Michael Szarek, Deepak L. Bhatt et autres

24 citationsEuropean Heart Journal - Cardiovascular Pharmacotherapy

2023 articleOpenAlex

The Association Between Liver Histology and Cardiovascular Risk: Time to Introduce Steatotic Liver Disease Screening in High-Risk Patient Groups?

Chrysoula Boutari, Vasilios G. Athyros

3 citationsAngiology

2023 articleOpenAlex

Hypertension-Mediated Organ Damage Detection: The Earlier the Hypertension Treatment, the Better

Chrysoula Boutari, Fotios Siskos, Vasilios G. Athyros

0 citationsCurrent Vascular Pharmacology

2023 articleOpenAlex

A Pilot Study Suggesting Several Benefits of Alpha Lipoic Acid in Patients with Diabetes

Vasilios G. Athyros, Sfikas George, Koumaras Charalambos, Athyrou Valasia

0 citationsCurrent Vascular Pharmacology

2022 articleOpenAlex

Inflammation and LDL Reduction

Vasilios G. Athyros, George Sfikas, Charalambos Koumaras

1 citationCurrent Vascular Pharmacology

Accès ouvert 2022 articleOpenAlex

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek, Deepak L. Bhatt et autres

125 citationsCirculation

2022 articleOpenAlex

Right ventricular performance in patients with heart failure with mildly reduced ejection fraction: the forgotten ventricle

Konstantinos Koutsampasopoulos, Ioannis Vogiatzis, Antonios Ziakas, Christodoulos Papadopoulos et autres

4 citationsThe International Journal of Cardiovascular Imaging

2021 articleOpenAlex

Clinical benefit of statin treatment on patients with non-alcoholic fatty liver disease or steatohepatitis

Vasilios G. Athyros, Niki Katsiki, Dimitri P. Mikhailidis

0 citationsClinics and Research in Hepatology and Gastroenterology

2021 articleOpenAlex

Serum uric acid: a mediator of cardio-reno-metabolic diseases

Niki Katsiki, Vasilios G. Athyros

3 citationsExpert Review of Cardiovascular Therapy

2021 articleOpenAlex

Serum adipokine levels in patients with type 1 diabetes are associated with degree of obesity but only resistin is independently associated with atherosclerosis markers

Erieta Kollari, Ioanna Zografou, Christos Sampanis, Vasilios G. Athyros et autres

12 citationsHORMONES

2021 articleOpenAlex

Arterial Stiffness as a Cardiovascular Risk Factor for the Development of Preeclampsia and Pharmacopreventive Options

Christos Anthoulakis, Apostolos Mamopoulos, D. Rousso, Asterios Karagiannis et autres

2 citationsCurrent Vascular Pharmacology

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.